HHS Spends $232.7M on Ventilators from Philips Amidst COVID-19 Pandemic
Contract Overview
Contract Amount: $232,740,000 ($232.7M)
Contractor: Philips North America LLC
Awarding Agency: Department of Health and Human Services
Start Date: 2020-03-30
End Date: 2021-03-29
Contract Duration: 364 days
Daily Burn Rate: $639.4K/day
Competition Type: NOT COMPETED
Number of Offers Received: 1
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: VENTILATORS COVID-19
Place of Performance
Location: ATLANTA, DEKALB County, GEORGIA, 30341
State: Georgia Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $232.7 million to PHILIPS NORTH AMERICA LLC for work described as: VENTILATORS COVID-19 Key points: 1. Significant expenditure on critical medical equipment during a national emergency. 2. Sole-source award to Philips raises questions about price discovery and competition. 3. Contract duration of one year aligns with immediate pandemic needs. 4. High value contract warrants scrutiny for potential waste or fraud.
Value Assessment
Rating: questionable
The contract value of $232.7 million for ventilators is substantial. Without comparable contract data for similar emergency procurements, it's difficult to definitively assess if the pricing was optimal. The lack of competition suggests potential for overpayment.
Cost Per Unit: N/A
Competition Analysis
Competition Level: sole-source
This contract was not competed, likely due to the urgent need for ventilators during the COVID-19 pandemic. This approach bypasses standard competitive processes, potentially leading to higher prices and reduced value for taxpayer money.
Taxpayer Impact: The sole-source nature of this large contract raises concerns about whether taxpayers received the best possible value, given the absence of competitive bidding.
Public Impact
Ensured critical supply of ventilators during a public health crisis. Potential for inflated costs due to lack of competition. Highlights reliance on single vendors during emergencies. Government's ability to rapidly procure essential medical supplies.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Sole-source award
- Lack of competition
- High contract value
Positive Signals
- Procured essential medical equipment
- Addressed critical need during pandemic
Sector Analysis
The healthcare sector, particularly medical equipment procurement, saw massive surges in spending during the COVID-19 pandemic. This contract falls under medical supplies, a category that experienced unprecedented demand and price volatility.
Small Business Impact
This contract was awarded to Philips North America LLC, a large corporation. There is no indication that small businesses were involved in this specific procurement, which is common for large-scale, specialized equipment needs during emergencies.
Oversight & Accountability
The sole-source nature of this contract warrants careful review by oversight bodies to ensure the funds were used appropriately and that the pricing was justified given the circumstances. Transparency in emergency procurements is crucial.
Related Government Programs
- Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
- Department of Health and Human Services Contracting
- Office of Assistant Secretary for Preparedness and Response Programs
Risk Flags
- Sole-source award
- Lack of competitive bidding
- High contract value
- Potential for price gouging
- Limited transparency
Tags
medical-dental-and-hospital-equipment-an, department-of-health-and-human-services, ga, definitive-contract, 100m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $232.7 million to PHILIPS NORTH AMERICA LLC. VENTILATORS COVID-19
Who is the contractor on this award?
The obligated recipient is PHILIPS NORTH AMERICA LLC.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).
What is the total obligated amount?
The obligated amount is $232.7 million.
What is the period of performance?
Start: 2020-03-30. End: 2021-03-29.
Was the $232.7 million price for these ventilators justified given the emergency context and the lack of competition?
Assessing justification is challenging without detailed cost breakdowns or benchmarks for comparable emergency ventilator procurements. The absence of competition inherently limits price discovery, making it difficult to ascertain if the price represented fair market value or was inflated due to urgent demand and limited supplier options.
What were the specific risks associated with awarding this contract solely to Philips North America LLC during the pandemic?
The primary risks included potential overpayment due to the lack of competitive bidding, over-reliance on a single supplier which could lead to supply chain vulnerabilities if Philips faced production issues, and a lack of transparency in the pricing mechanism. This also limits opportunities for other qualified vendors.
How effective was this procurement in meeting the nation's critical need for ventilators during the COVID-19 crisis?
The procurement was likely effective in securing a large quantity of ventilators, which were in extremely high demand. However, the effectiveness in terms of value for money is questionable due to the sole-source nature. The ultimate impact depends on the actual deployment and utilization of these ventilators.
Industry Classification
NAICS: Wholesale Trade › Professional and Commercial Equipment and Supplies Merchant Wholesalers › Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Competition & Pricing
Extent Competed: NOT COMPETED
Solicitation Procedures: ONLY ONE SOURCE
Offers Received: 1
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Koninklijke Philips N.V.
Address: 3000 MINUTEMAN RD MS 0077, ANDOVER, MA, 01810
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations
Financial Breakdown
Contract Ceiling: $232,740,000
Exercised Options: $232,740,000
Current Obligation: $232,740,000
Actual Outlays: $212,442,047
Contract Characteristics
Commercial Item: COMMERCIAL ITEM
Cost or Pricing Data: NO
Timeline
Start Date: 2020-03-30
Current End Date: 2021-03-29
Potential End Date: 2021-03-29 00:00:00
Last Modified: 2026-03-31
More Contracts from Philips North America LLC
- This System Would BE Used and Integrated Within Routine Care for Burns and Traumatic Injuries, BUT Would Also Have the Potential to BE of USE in Detection Viral Pneumonia of Covid 19 Cases — $68.2M (Department of Health and Human Services)
- Patient Monitoring Equipment System, Anesthesia Record Keeping System, Event Management Alarm System and Related Items for Visn 22 — $26.4M (Department of Veterans Affairs)
- Physiological Monitors and Wireless Telemetry for Visn 15 — $23.8M (Department of Veterans Affairs)
- 8510393041!patient Monitoring SYS — $22.1M (Department of Defense)
- Rapidly Operationalize the Rapid Analysis of Threat Exposure (rate) Algorithm — $14.9M (Department of Defense)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →